Peregrine Pharma (PPHM) Reports In-Line Q3 Loss of 13c/Share
Tweet Send to a FriendGet Alerts PPHM Hot Sheet
Price: $1.48 -1.33%
EPS Growth %: +69.2%
Financial Fact:
Contract manufacturing revenue: 6.96M
Today's EPS Names:
CEDU, CHC, CIDM, More
EPS Growth %: +69.2%
Financial Fact:
Contract manufacturing revenue: 6.96M
Today's EPS Names:
CEDU, CHC, CIDM, More
Trade PPHM Now!
Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) reported Q3 EPS of ($0.13), in-line with the analyst estimate of ($0.13). Revenue for the quarter came in at $3.28 million versus the consensus estimate of $2.12 million.
For earnings history and earnings-related data on Peregrine Pharmaceuticals, Inc. (PPHM) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Peregrine Pharmaceuticals, Inc. (PPHM) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Jabil Circuit (JBL) Tops Q3 EPS by 2c; Issues Light Q4 Outlook; Will Realign Global Ops
- Actuant Corp. (ATU) Tops Q3 EPS by 3c; Trims FY13 Outlook, Guides FY14
- Cinedigm Digital Cinema (CIDM) Tops Q4 EPS by 1c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
